141 related articles for article (PubMed ID: 9694729)
1. The chimeric E2A-HLF transcription factor abrogates p53-induced apoptosis in myeloid leukemia cells.
Altura RA; Inukai T; Ashmun RA; Zambetti GP; Roussel MF; Look AT
Blood; 1998 Aug; 92(4):1397-405. PubMed ID: 9694729
[TBL] [Abstract][Full Text] [Related]
2. The AD1 and AD2 transactivation domains of E2A are essential for the antiapoptotic activity of the chimeric oncoprotein E2A-HLF.
Inukai T; Inaba T; Ikushima S; Look AT
Mol Cell Biol; 1998 Oct; 18(10):6035-43. PubMed ID: 9742120
[TBL] [Abstract][Full Text] [Related]
3. Pivotal role for the NFIL3/E4BP4 transcription factor in interleukin 3-mediated survival of pro-B lymphocytes.
Ikushima S; Inukai T; Inaba T; Nimer SD; Cleveland JL; Look AT
Proc Natl Acad Sci U S A; 1997 Mar; 94(6):2609-14. PubMed ID: 9122243
[TBL] [Abstract][Full Text] [Related]
4. The proto-oncogene HLF and the related basic leucine zipper protein TEF display highly similar DNA-binding and transcriptional regulatory properties.
Hunger SP; Li S; Fall MZ; Naumovski L; Cleary ML
Blood; 1996 Jun; 87(11):4607-17. PubMed ID: 8639829
[TBL] [Abstract][Full Text] [Related]
5. The E2A-HLF oncoprotein activates Groucho-related genes and suppresses Runx1.
Dang J; Inukai T; Kurosawa H; Goi K; Inaba T; Lenny NT; Downing JR; Stifani S; Look AT
Mol Cell Biol; 2001 Sep; 21(17):5935-45. PubMed ID: 11486032
[TBL] [Abstract][Full Text] [Related]
6. Reversal of apoptosis by the leukaemia-associated E2A-HLF chimaeric transcription factor.
Inaba T; Inukai T; Yoshihara T; Seyschab H; Ashmun RA; Canman CE; Laken SJ; Kastan MB; Look AT
Nature; 1996 Aug; 382(6591):541-4. PubMed ID: 8700228
[TBL] [Abstract][Full Text] [Related]
7. DNA-binding specificity and trans-activating potential of the leukemia-associated E2A-hepatic leukemia factor fusion protein.
Inaba T; Shapiro LH; Funabiki T; Sinclair AE; Jones BG; Ashmun RA; Look AT
Mol Cell Biol; 1994 May; 14(5):3403-13. PubMed ID: 8164688
[TBL] [Abstract][Full Text] [Related]
8. DNA-binding and transcriptional regulatory properties of hepatic leukemia factor (HLF) and the t(17;19) acute lymphoblastic leukemia chimera E2A-HLF.
Hunger SP; Brown R; Cleary ML
Mol Cell Biol; 1994 Sep; 14(9):5986-96. PubMed ID: 8065331
[TBL] [Abstract][Full Text] [Related]
9. Interferon-gamma inhibits apoptosis induced by wild-type p53, cytotoxic anti-cancer agents and viability factor deprivation in myeloid cells.
Lotem J; Sachs L
Leukemia; 1995 Apr; 9(4):685-92. PubMed ID: 7723404
[TBL] [Abstract][Full Text] [Related]
10. SLUG, a ces-1-related zinc finger transcription factor gene with antiapoptotic activity, is a downstream target of the E2A-HLF oncoprotein.
Inukai T; Inoue A; Kurosawa H; Goi K; Shinjyo T; Ozawa K; Mao M; Inaba T; Look AT
Mol Cell; 1999 Sep; 4(3):343-52. PubMed ID: 10518215
[TBL] [Abstract][Full Text] [Related]
11. Cell transformation mediated by homodimeric E2A-HLF transcription factors.
Inukai T; Inaba T; Yoshihara T; Look AT
Mol Cell Biol; 1997 Mar; 17(3):1417-24. PubMed ID: 9032268
[TBL] [Abstract][Full Text] [Related]
12. Two candidate downstream target genes for E2A-HLF.
Kurosawa H; Goi K; Inukai T; Inaba T; Chang KS; Shinjyo T; Rakestraw KM; Naeve CW; Look AT
Blood; 1999 Jan; 93(1):321-32. PubMed ID: 9864177
[TBL] [Abstract][Full Text] [Related]
13. E2A-HLF-mediated cell transformation requires both the trans-activation domains of E2A and the leucine zipper dimerization domain of HLF.
Yoshihara T; Inaba T; Shapiro LH; Kato JY; Look AT
Mol Cell Biol; 1995 Jun; 15(6):3247-55. PubMed ID: 7760820
[TBL] [Abstract][Full Text] [Related]
14. E2A-HLF usurps control of evolutionarily conserved survival pathways.
Seidel MG; Look AT
Oncogene; 2001 Sep; 20(40):5718-25. PubMed ID: 11607821
[TBL] [Abstract][Full Text] [Related]
15. Disrupted differentiation and oncogenic transformation of lymphoid progenitors in E2A-HLF transgenic mice.
Smith KS; Rhee JW; Naumovski L; Cleary ML
Mol Cell Biol; 1999 Jun; 19(6):4443-51. PubMed ID: 10330184
[TBL] [Abstract][Full Text] [Related]
16. Chimeric oncoprotein E2a-Pbx1 induces apoptosis of hematopoietic cells by a p53-independent mechanism that is suppressed by Bcl-2.
Smith KS; Jacobs Y; Chang CP; Cleary ML
Oncogene; 1997 Jun; 14(24):2917-26. PubMed ID: 9205098
[TBL] [Abstract][Full Text] [Related]
17. CREB is one component of the binding complex of the Ces-2/E2A-HLF binding element and is an integral part of the interleukin-3 survival signal.
Chen W; Yu YL; Lee SF; Chiang YJ; Chao JR; Huang JH; Chiong JH; Huang CJ; Lai MZ; Yang-Yen HF; Yen JJ
Mol Cell Biol; 2001 Jul; 21(14):4636-46. PubMed ID: 11416141
[TBL] [Abstract][Full Text] [Related]
18. Expression of E2A-HLF chimeric protein induced T-cell apoptosis, B-cell maturation arrest, and development of acute lymphoblastic leukemia.
Honda H; Inaba T; Suzuki T; Oda H; Ebihara Y; Tsuiji K; Nakahata T; Ishikawa T; Yazaki Y; Hirai H
Blood; 1999 May; 93(9):2780-90. PubMed ID: 10216071
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of HIF-1- and wild-type p53-stimulated transcription by codon Arg175 p53 mutants with selective loss of functions.
Blagosklonny MV; Giannakakou P; Romanova LY; Ryan KM; Vousden KH; Fojo T
Carcinogenesis; 2001 Jun; 22(6):861-7. PubMed ID: 11375890
[TBL] [Abstract][Full Text] [Related]
20. Relationship of sequence-specific transactivation and p53-regulated apoptosis in interleukin 3-dependent hematopoietic cells.
Gottlieb E; Lindner S; Oren M
Cell Growth Differ; 1996 Mar; 7(3):301-10. PubMed ID: 8838860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
